abrdn Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,061,139
| Closed | -$57.7M | – | 197 |
|
|
2017
Q1 | $57.7M | Sell |
1,061,139
-43,315
| -4% | -$2.36M | 0.19% | 118 |
|
|
2016
Q4 | $64.6M | Sell |
1,104,454
-25,138
| -2% | -$1.47M | 0.22% | 117 |
|
|
2016
Q3 | $60.9M | Sell |
1,129,592
-1,549,609
| -58% | -$83.6M | 0.25% | 105 |
|
|
2016
Q2 | $197M | Buy |
2,679,201
+667,412
| +33% | +$49.1M | 0.89% | 43 |
|
|
2016
Q1 | $128M | Sell |
2,011,789
-673,235
| -25% | -$43M | 0.59% | 63 |
|
|
2015
Q4 | $185M | Buy |
2,685,024
+128,507
| +5% | +$8.84M | 0.78% | 47 |
|
|
2015
Q3 | $151M | Sell |
2,556,517
-1,383,650
| -35% | -$81.9M | 0.65% | 54 |
|
|
2015
Q2 | $262M | Buy |
3,940,167
+1,772,140
| +82% | +$118M | 1.11% | 37 |
|
|
2015
Q1 | $140M | Buy |
2,168,027
+2,101,207
| +3,145% | +$136M | 0.57% | 66 |
|
|
2014
Q4 | $3.94M | Sell |
66,820
-2,506
| -4% | -$148K | 0.02% | 183 |
|
|
2014
Q3 | $3.55M | Sell |
69,326
-936
| -1% | -$47.9K | 0.01% | 191 |
|
|
2014
Q2 | $3.41M | Sell |
70,262
-2,443
| -3% | -$118K | 0.02% | 186 |
|
|
2014
Q1 | $3.78M | Sell |
72,705
-48,911
| -40% | -$2.54M | 0.02% | 164 |
|
|
2013
Q4 | $6.46M | Buy |
121,616
+9,602
| +9% | +$510K | 0.03% | 173 |
|
|
2013
Q3 | $5.18M | Buy |
112,014
+4,049
| +4% | +$187K | 0.03% | 161 |
|
|
2013
Q2 | $4.83M | Buy |
+107,965
| New | +$4.83M | 0.03% | 163 |
|